Acuta Capital Partners’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-378,715
| Closed | -$10M | – | 55 |
|
|
2022
Q2 | $10M | Sell |
378,715
-12,494
| -3% | -$330K | 5.57% | 3 |
|
|
2022
Q1 | $14.6M | Hold |
391,209
| – | – | 6.8% | 3 |
|
|
2021
Q4 | $22.9M | Buy |
391,209
+275
| +0.1% | +$16.1K | 9.62% | 3 |
|
|
2021
Q3 | $32.1M | Hold |
390,934
| – | – | 11.34% | 2 |
|
|
2021
Q2 | $36.9M | Sell |
390,934
-18,925
| -5% | -$1.79M | 14.76% | 1 |
|
|
2021
Q1 | $26.2M | Buy |
409,859
+159,859
| +64% | +$10.2M | 9.44% | 1 |
|
|
2020
Q4 | $14.6M | Buy |
+250,000
| New | +$14.6M | 3.96% | 7 |
|